SASP
英
美
网络 磺胺吡啶; 柳氮磺胺嘧啶; 柳氮磺嘧啶; 柳氮磺胺吡啶; 柳氮磺吡啶
双语例句
- Objective To approach the clinical therapeutic effects on light or mid-range ulcerative colitis by small dose sulfasalazine ( SASP), Danshen root injection, association with Liushen pill.
目的探讨小剂量柳氮磺胺吡啶（SASP）口服、丹参注射液静滴联合六神丸、云南白药保留灌肠治疗活动期轻中度溃疡性结肠炎的临床疗效。 - Methods The changes of pathological signs and histological grades of UC were observed before and after the treatment with SASP 1 g three times daily for six weeks.
方法应用SASP1g，每日3次，治疗活动期UC6周，观察治疗前后的病理特征和组织学分级的变化。 - Another group with MTX 10 mg/ week and salicylazosulfapyridine ( SASP) 2 0 g/ day, for 12 weeks.
第2组服用MTX10mg/周+柳氮磺吡啶（SASP）10g，每日2次，观察3个月。 - CONCLUSION: SASP ( 3 g per day) can be an effective and safe medicine in treatment of patients with mild and moderate UC, but more than half of the patients in clinical remission still have light inflammation in colonoscopy and histology.
结论：SASP3g·d-1治疗轻中型溃疡性结肠炎的近期疗效和安全性较好，尤以临床症状改善显著，但临床缓解的病人中一半以上仍有结肠黏膜的轻度炎症。 - Conclusion: The effect of combined medication is more effective, which is superior to SASP and probiotic group.
结论：培菲康胶囊与柳氮磺胺毗淀均可有效治疗浅，且联合用药效果更佳。 - Thirty-two AS cases were treated by comprehensive methods: orally taken TCD, internally applied SASP and MTX combined with TCD-steam bath and functional exercises.
运用内服中药和SASP及MTX内服，配合中药蒸汽浴及功能锻炼综合治疗强直性脊柱炎32例。 - Objective: To observe the efficacy and safety of Etiasa, a control released tablet of mesalazine, in treatment of inflammatory bowel disease ( IBD) in comparison with salicylazosulfapyridine ( SASP).
目的：观察一种新型美沙拉嗪控释剂（艾迪莎）治疗炎症性肠病（IBD）的疗效和安全性，并同水杨酸偶氮磺胺吡啶（SASP）进行比较。 - The rate of side effect was SASP ( 20%)
副作用发生率SASP（20%） - AIM: To observe the curative effect of Sanguis Draconis combined with salicylazosulfapyridine ( SASP) in the treatment of non-specific ulcerative colitis ( UC).
目的：观察血竭联合柳氮磺吡啶治疗非特异性溃疡性结肠炎（UC）的疗效。 - The last 20 patients of a control group received Salicylazosulfapyridine ( SASP) 1.0, qid. The duration of treatment was four weeks in all groups.
对照组20例，口服柳氮磺吡啶（SASP）1.0qd，疗程均为4周。 - Etiasa and SASP have similar therapeutic effects on TNBS-induced rat model of ulcerative colitis.
艾迪莎和SASP在对大鼠溃疡性结肠炎的治疗疗效相似。 - Bnfillus licheniformis has been therapeutical effect to DSS-induced acute ulcerative colitis in mice, and there was more effective when the administration of it combined with SASP. 2.
结论：1.地衣芽孢杆菌对DSS诱导的小鼠急性溃疡性结肠炎有治疗作用，且与柳氮磺胺吡啶联合给药时治疗作用更明显。 - Activities were divided into two groups of experimental group ( 30 cases), to SASP 1g/ 4 times/ day, oral, combination of oral and retention-enema of TCM.
活动期随机分为两组，试验组（30例），给予SASP1g/次，4次/日，口服，并合中药口服加灌肠。 - Currently, aminosalicylic acid ( ASA) including Etiasa and SASP is the main and basic medication for the treatment of UC in human.
当前，氨基水杨酸类药物如艾迪莎和柳氮磺胺吡啶（sulfasalazin，SASP）是治疗溃疡性结肠炎的主要和基本药物。